Infection With Chlamydia Trachomatis Diagnosed by Use of NAATs [Nucleic Acid Amplification Test] 1-year post-treatment [clinicaltrials_resource:1930bf2cdb93c975af4113f632b8b6f9]
Subjects residing in villages assigned to treatment arm 2 will receive a clinical evaluation for trachoma and provide a swab specimen of conjunctivae of the R eye at enrollment (Day 0), as well as receive an initial treatment with 1 gm oral dose of Azithromycin; receive a second 1 gm oral dose of Azithromycin at Day 30; be re-screened (clinical evaluation and swab specimen of R eye collected) at Day 60 and Day 360.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Infection With Chlamydia Trachomatis Diagnosed by Use of NAATs [Nucleic Acid Amplification Test] 1-year post-treatment [clinicaltrials_resource:1930bf2cdb93c975af4113f632b8b6f9]
Subjects residing in villages assigned to treatment arm 2 will receive a clinical evaluation for trachoma and provide a swab specimen of conjunctivae of the R eye at enrollment (Day 0), as well as receive an initial treatment with 1 gm oral dose of Azithromycin; receive a second 1 gm oral dose of Azithromycin at Day 30; be re-screened (clinical evaluation and swab specimen of R eye collected) at Day 60 and Day 360.
Bio2RDF identifier
1930bf2cdb93c975af4113f632b8b6f9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1930bf2cdb93c975af4113f632b8b6f9
measure [clinicaltrials_vocabulary:measure]
Infection With Chlamydia Trach ...... cleic Acid Amplification Test]
time frame [clinicaltrials_vocabulary:time-frame]
1-year post-treatment
description
Subjects residing in villages ...... lected) at Day 60 and Day 360.
identifier
clinicaltrials_resource:1930bf2cdb93c975af4113f632b8b6f9
title
Infection With Chlamydia Trach ...... on Test] 1-year post-treatment
@en
type
label
Infection With Chlamydia Trach ...... 0bf2cdb93c975af4113f632b8b6f9]
@en